Intracorporeal glucose disposal during hemodialysis after a standardized glucose load

ASAIO Journal

Volumn 56, Issue 3, 2010, Pages 204-209

  Schneditz, Daniel ^a   Hafner Giessauf, Hildegard ^a   Holzer, Herwig ^a   Thomaseth, Karl ^b  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD SAMPLING; DIABETIC PATIENT; DIALYSATES; GLUCOSE CONTROL; HEMODIALYSIS PATIENT; HIGHLY-CORRELATED; MASS BALANCE; SHORT-INTERVAL;

BLOOD; DIALYSIS; HEMODIALYZERS;

GLUCOSE;

DIALYSIS FLUID; GLUCOSE;

ARTICLE; DRUG ADMINISTRATION ROUTE; EXTRACORPOREAL CIRCULATION; FEMALE; HUMAN; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; RENAL REPLACEMENT THERAPY;

DIALYSIS SOLUTIONS; DRUG ADMINISTRATION ROUTES; EXTRACORPOREAL CIRCULATION; FEMALE; GLUCOSE; HUMANS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; RENAL DIALYSIS;

EID: 77951992405     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAT.0b013e3181ce1c9b     Document Type: Article

References (19)

1. Bouffard Y, Tissot S, Delafosse B, et al: Metabolic effects of hemodialysis with and without glucose in the dialysate. Kidney Int 43:43-1086, 1993.
2. Burmeister JE, Scapini A, da Rosa Miltersteiner D, et al: Glucoseadded dialysis fluid prevents asymptomatic hypoglycaemia in regular haemodialysis. Nephrol Dial Transplant 22:22-1184, 2007.
3. Ritchie-McLean S, Kirwan C, Levy JB: Is there a role for intensive insulin therapy in patients with kidney disease? Am J Kidney Dis 50:50-371, 2007.
4. Uzu T, Hatta T, Deji N, et al: Target for glycemic control in type 2 diabetic patients on hemodialysis: Effects of anemia and erythropoietin injection on hemoglobin A1c. Ther Apher Dial 13:13-89, 2009.
5. Riveline JP, Teynie J, Belmouaz S, et al: Glycaemic control in type 2 diabetic patients on chronic haemodialysis: Use of a continuous glucose monitoring system. Nephrol Dial Transplant 24:24-2866, 2009.
6. Kazempour-Ardebili S, Lecamwasam VL, Dassanyake T, et al: Assessing glycemic control in maintenance hemodialysis patients with type 2 diabetes. Diabetes Care 32:32-1137, 2009.
7. Depner TA: Refinements and application of urea modeling, in Depner TA (ed), Prescribing Hemodialysis: A Guide to Urea Modeling. Boston/Dordrecht/ London, Kluwer Academic Publishers, 1991, pp. 167-194.
8. Schneditz D, Kaufman AM, Polaschegg HD, et al: Cardiopulmonary recirculation during hemodialysis. Kidney Int 42:1450-1456, 1992.
9. Schneditz D: Glucose-added dialysis fluid prevents asymptomatic hypoglycaemia in regular haemodialysis. Nephrol Dial Transplant 23:23-1066, 2008.
10. Schneditz D, Hafner-Giessauf H, Holzer H, Thomaseth K: Intraand extracorporeal clearance of glucose following an intradialytic glucose load, in Dössel O, Schlegel WC (eds), IFMBE Proceedings. Munich, the World Congress on Medical Physics and Biomedical Engineering, 2009, 25 (VII), pp. 855-858.
11. Ferrannini E, Pilo A, Tuoni M: The response to intravenous glucose of patients on maintenance hemodialysis: Effects of dialysis. Metabolism 28:28-125, 1979.
12. Allegra V, Mengozzi G, Martimbianco L, Vasile A: Glucoseinduced insulin secretion in uremia: Effects of aminophylline infusion and glucose loads. Kidney Int 38:38-1146, 1990.
13. Mari A, Stojanovska L, Proietto J, Thorburn AW: A circulatory model for calculating non-steady-state glucose fluxes. Validation and comparison with compartmental models. Comput Meth Programs Biomed 71:71-269, 2003.
14. Thomaseth K, Pavan A, Berria R, et al: Model-based assessment of insulin sensitivity of glucose disposal and endogenous glucose production from double-tracer oral glucose tolerance test. Comput Meth Programs Biomed 89:89-132, 2008.
15. Brehm A, Thomaseth K, Bernroider E, et al: The role of endocrine counterregulation for estimating insulin sensitivity from intravenous glucose tolerance tests. J Clin Endocrinol Metab 91:91-2272, 2006.
16. Jakob SM, Ruokonen E, Vuolteenaho O, et al: Splanchnic perfusion during hemodialysis: evidence for marginal tissue perfusion. Crit Care Med 29:29-1393, 2001.
17. Rigalleau V, Baillet L, Lasseur C, et al: Splanchnic tissues play a crucial role in uremic glucose intolerance. J Renal Nutr 13:13-212, 2003.
18. Hirota K, Ishihara H, Tsubo T, Matsuki A: Estimation of the initial distribution volume of glucose by an incremental plasma glucose level at 3 min after i.v. glucose in humans. Br J Clin Pharmacol 47:47-361, 1999.
19. Ishihara H, Suzuki A, Okawa H, et al: Comparison of initial distribution volume of glucose and plasma volume in thoracic fluidaccumulated patients. Crit Care Med 29:29-1532, 2001.